The first GWAS for pancreatic cancer identified common risk variants that map to the first intron of the ABO gene on chromosome 9q34.27, corroborating earlier epidemiologic findings showing a lower risk among individuals with blood group O than those with blood group A or B12, 13. The gene discussed is ABO; the disease is pancreatic neoplasm.